The combination of two proteins exerts a regenerating effect in Parkinson’s disease
Current therapies for Parkinson’s disease are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed. Researcher have now documented the regenerative, neuroprotective effect of two neurotrophic factors when they are applied in a combined way. …read more
